Table of Contents
Definition / general | Terminology | Pathophysiology | Etiology | Diagrams / tables | Clinical features | Radiology images | Treatment | Gross description | Gross images | Microscopic (histologic) description | Positive stains | Electron microscopy description | Differential diagnosis | Additional referencesCite this page: Weisenberg E. Achalasia and motor disorders. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/esophagusachalasia.html. Accessed December 21st, 2024.
Definition / general
- Esophageal motor disorder characterized by lack of progressive peristalsis and partial / incomplete relaxation of lower esophageal sphincter (LES), preventing passage of food into stomach
- Preferentially involves circular layer of muscularis propria, which is hypertrophied
- Patients with achalasia may also have GERD (Eur J Gastroenterol Hepatol 2006;18:369)
- 5% risk (33x normal) of esophageal squamous cell carcinoma, at mean 21 - 28 years after diagnosis of achalasia (Anticancer Res 2000;20:3717)
- Also increased risk of aspiration, Barrett esophagus, Candida infection, gastroesophageal reflux, lower esophageal diverticula, peptic ulceration, stricture (Ann Surg 2006;243:196)
Terminology
- Also called cardiospasm, megaesophagus
Pathophysiology
- Due to T cell mediated destruction or complete absence of myenteric ganglion cells in lower third of esophagus (Am J Gastroenterol 2005;100:1404)
Etiology
- Secondary causes: Allgrove syndrome (World J Gastroenterol 2006;12:4764), amyloidosis, Chagas disease (Trypanosoma cruzi, common in South America, destroys myenteric plexus of esophagus, duodenum, colon, ureter), diabetic autonomic neuropathy, polio, sarcoidosis, surgical ablation of dorsal motor nuclei, thyroid disease (World J Gastroenterol 2007;13:594), tumor
Clinical features
- Most cases are primary, i.e. idiopathic, usually young adults with progressive dysphagia, nocturnal regurgitation and aspiration of undigested food
- Can occur in children
Treatment
- Esophagomyotomy (World J Gastroenterol 2006;12:5921, GI Motility Online: Surgical Treatment for Achalasia [Accessed 13 February 2019]), dilation (World J Gastroenterol 2006;12:5763), botulinum toxin to inhibit LES cholinergic neurons
Gross description
- Progressive dilation of esophagus above LES, variable wall thickness
Microscopic (histologic) description
- Early: Auerbach / myenteric plexus has lymphocytic inflammation (cytotoxic T cells, eosinophils) with germinal centers and submucosal glandular atrophy
- Late: marked depletion / absence of ganglion cells in myenteric plexus (middle of esophagus, may be normal at LES) and replacement of nerves by collagen with muscular hypertrophy; squamous mucosa markedly hyperplastic with papillomatosis and basal cell hyperplasia resembling GERD (J Gastroenterol Hepatol 2006;21:727)
Positive stains
- p53, T > B cells (Am J Surg Pathol 2001;25:1413)
Electron microscopy description
- Smooth muscle cells have nuclear and cytoplasmic inclusions, marked loss of small nerve fibers, paucity of granules in nerve fibers; also nonspecific filament disarray, mottling of myocyte fiber density, thick and long cytoplasmic dense bodies, long dense plaques (Am J Clin Pathol 1983;79:319)
Differential diagnosis
- Normal aging
- Pseudoachalasia
- Visceral neuropathies
Additional references
- Am J Surg Pathol 1994;18:327, Wikipedia: Achalasia [Accessed 13 February 2019], eMedicine: Achalasia [Accessed 13 February 2019], GI Motility Online: Pathophysiology of Achalasia and Diffuse Esophageal Spasm [Accessed 13 February 2019], Kumar: Robbins and Cotran Pathologic Basis of Disease, 8th Edition, 2009